Status:
COMPLETED
Evaluating Improvement Strategies in Addiction Treatment
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)
Conditions:
Addiction
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Addiction treatment is often characterized by long delays between first contact and treatment as well as high no-show and drop out rates leading to unused capacity in apparently full agencies. Patient...
Detailed Description
This cluster-RCT randomly assign 201 treatment agencies in 5 states to four experimental arms. The agencies were randomized to an intervention for 18 months with a 9 month sustainability period. The s...
Eligibility Criteria
Inclusion
- at least 60 admissions/year
- provide outpatient and intensive outpatient levels of care (as defined by ASAM)
- provide or use detox services provided by others
- have tax-exempt or government status or rely on public funding (e.g., block grants, Medicare, Medicaid, local government, private philanthropy) for at least 50% of their budget
- have adopted no more than two of the planned interventions
Exclusion
- are current NIATx members
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00934141
Start Date
October 1 2006
End Date
January 1 2011
Last Update
August 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisonsin-Madison
Madison, Wisconsin, United States, 53706